Both molnupiravir and ritonavir-boosted nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance in patients with COVID-19, but the antiviral effect of ritonavir-boosted nirmatrelvir was substantially greater. Measurement of oropharyngeal viral...
Both molnupiravir and ritonavir-boosted nirmatrelvir accelerate oropharyngeal SARS-CoV-2 viral clearance in patients with COVID-19, but the antiviral effect of ritonavir-boosted nirmatrelvir was substantially greater. Measurement of oropharyngeal viral...
The trial reported by William Schilling and colleagues1 in The Lancet Infectious Diseases adds crucial data to guide treatment decisions between clinicians and patients at this stage of the COVID-19 pandemic. This appears to be the first published rand...
After a prolonged period of near-complete global dominance of the recombinant XBB family of SARS-CoV-2 lineages, a substantially mutated sublineage of BA.2 has recently emerged. Designated BA.2.86,1 the geographic origin of this sublineage is currently...
Litvinjenko S, Magwood O, Wu S, Wei X. Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews. Lancet Infect Dis 2023; published online Sept 8. https://doi.org/10.1016/S1473-3099(23)00372-9—This Article should ...
Litvinjenko S, Magwood O, Wu S, Wei X. Burden of tuberculosis among vulnerable populations worldwide: an overview of systematic reviews. Lancet Infect Dis 2023; published online Sept 8. https://doi.org/10.1016/S1473-3099(23)00372-9—This Article should ...
Dengue poses an ongoing public health threat in most tropical and subtropical regions, and is poised to increase further in incidence and geographic distribution.1 The Laboratory of Infectious Diseases at the National Institutes of Health (NIH)–Nationa...
Dengue poses an ongoing public health threat in most tropical and subtropical regions, and is poised to increase further in incidence and geographic distribution.1 The Laboratory of Infectious Diseases at the National Institutes of Health (NIH)–Nationa...
After a prolonged period of near-complete global dominance of the recombinant XBB family of SARS-CoV-2 lineages, a substantially mutated sublineage of BA.2 has recently emerged. Designated BA.2.86,1 the geographic origin of this sublineage is currently...
Despite low coverage, the protective efficacy against malaria offered by chlorfenapyr–PY LLINs was superior to that provided by standard PY LLINs over a 3-year LLIN lifespan. Appropriate LLIN replacement strategies to maintain adequate usage of nets wi...
Despite low coverage, the protective efficacy against malaria offered by chlorfenapyr–PY LLINs was superior to that provided by standard PY LLINs over a 3-year LLIN lifespan. Appropriate LLIN replacement strategies to maintain adequate usage of nets wi...
Pyrethroid (PY) resistance is now rampant in most malaria-endemic countries, threatening to lower the effectiveness of standard long-lasting insecticide nets (LLINs) treated with PY only. Of the 88 countries that reported data on insecticide resistance...
Pyrethroid (PY) resistance is now rampant in most malaria-endemic countries, threatening to lower the effectiveness of standard long-lasting insecticide nets (LLINs) treated with PY only. Of the 88 countries that reported data on insecticide resistance...
With 3 years of follow-up, the single-dose tetravalent dengue vaccine, TV005, was well tolerated and immunogenic for all four serotypes in young children to adults, including individuals with no previous dengue exposure.
With 3 years of follow-up, the single-dose tetravalent dengue vaccine, TV005, was well tolerated and immunogenic for all four serotypes in young children to adults, including individuals with no previous dengue exposure.
Increasing the total dose of primaquine from 3·5 mg/kg to 7 mg/kg can reduce P vivax recurrences by more than 50% in most endemic regions, with a small associated increase in gastrointestinal symptoms.